Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greater-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greater

Published:2019-12 Issue: Volume:138 Page:88-94
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

She Longjiang,Hu Huabin,Liao Mengting,Xia Xuefeng,Shi Yin,Yao Linli,Ding Dong,Zhu Youwen,Zeng Shan,Shen Liangfang,Huang Jin^ORCID,Carbone David P.^ORCID

Funder

Hunan Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference38 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Integrative bioinformatics analysis reveals potential long non-coding RNA biomarkers and analysis of function in non-smoking females with lung Cancer;Qiao;Med. Sci. Monit.,2018

3. RAC1 polymorphisms affected platinum-based chemotherapy toxicity in lung cancer patients;Zou;Cancer Chemother. Pharmacol.,2016

4. Microarray data re-annotation reveals specific lncRNAs and their potential functions in non-small cell lung cancer subtypes;Zhou;Mol. Med. Rep.,2017

5. Cancer treatment and survivorship statistics;Miller;CA Cancer J. Clin.,2019

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of nivolumab plus gemcitabine-cisplatin as first-line treatment for advanced urothelial carcinoma in China and the United States;Frontiers in Immunology;2024-09-13

2. Metformin is a potential therapeutic for COVID-19/LUAD by regulating glucose metabolism;Scientific Reports;2024-05-30

3. Cost-effectiveness analysis of durvalumab, tremelimumab, and etoposide-platinum in first-line treatment of extensive-stage small cell lung cancer;Medicine;2024-04-19

4. EZH2 Inhibition Enhances PD‐L1 Protein Stability Through USP22‐Mediated Deubiquitination in Colorectal Cancer;Advanced Science;2024-03-22

5. Cost-Effectiveness of Treatment Optimisation with Biomarkers for Immunotherapy in Solid Tumours: A Systematic Review;Cancers;2024-02-29